Agoracom Blog Home

Posts Tagged ‘CBD’

INTERVIEW: Bougainville $BOG.ca Accelerates Vertical Integration With 5 Marijuana Locations In Alberta + Hemp CBD In Oregon $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 6:09 PM on Tuesday, April 23rd, 2019

Bougainville (BOG:CSE) has laid a strong foundation for growth – literally – by establishing itself as the landlord to smaller USA marijuana growers that needed a turnkey solution.  With it’s first tenant moving into 10,000 square feet this June in Washington State and adding another 20,000 thereafter, the Company is confidently branching out to become a vertically integrated producer and retailer in Canada. 

Most companies would be happy with two lines of business but BOG is adding a 3rd line via Hemp CBD production in Oregon.

Watch this video to learn more about Bougainville Ventures (BOG:CSE).

Vertical Exploration $VERT.ca Joins Prestigious International Fertilizer Industry Association $TORR.ca $FA.ca

Posted by AGORACOM at 9:17 AM on Wednesday, April 17th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564648/hub/vertical.png
  • Now a member of the International Fertilizer Industry Association (IFA )
  • The IFA is a non-profit organization based in Paris, France that represents the global fertilizer industry
  • Joined to promote and strategically market it’s world-class St-Onge wollastonite to a range of potential end-users
  • IFA member companies represent all activities related to the production, trade, transport, and distribution of every type of fertilizer

VANCOUVER, BC / ACCESSWIRE / April 17, 2019 / VERTICAL EXPLORATION INC. (TSX-V: VERT) (“Vertical” or “the Company”) is pleased to announce that it has become a member of the International Fertilizer Industry Association (IFA), as part of its ongoing efforts to promote and strategically market it’s world-class St-Onge wollastonite to a range of potential end-users.

The IFA is a non-profit organization based in Paris, France that represents the global fertilizer industry, on issues related to the promotion of plant nutrients, improvement of the operating environment of the member companies and the collection and compilation of industry information (https://www.fertilizer.org/). The IFA has a total of 476 members in 67 countries, including member organizations involved in construction, engineering, consulting, agronomic research and training. IFA’s core mission is to promote the efficient and responsible production, distribution, and use of plant nutrients.

IFA member companies represent all activities related to the production, trade, transport, and distribution of every type of fertilizer, ultimately serving farmers everywhere in order to meet the world’s growing food, feed, fibre and bioenergy needs in a sustainable manner.

Vertical’s membership in the IFA will allow it to showcase its wollastonite resource to a much wider global audience. Vertical strongly believes its natural wollastonite will help increase plant production for farmers and growers, by providing a unique combination of bio-available nutrients, such as silicon and calcium, that are essential to maintaining plant quality and stress tolerance during the critical stages of plant growth.

Vertical is also planning to attend the upcoming IFA 2019 Annual Conference taking place June 11-13th in Montreal, Quebec. This conference should provide additional opportunities for Vertical management and directors to meet with other IFA members, and potentially generate strategic partnerships that will aid in the marketing and future sales of its St-Onge wollastonite.

ABOUT VERTICAL EXPLORATION

Vertical Exploration’s mission is to identify, acquire, and advance high potential mining prospects located in North America for the benefit of its stakeholders. The Company’s flagship St-Onge Wollastonite property is located in the Lac-Saint-Jean area in the Province of Quebec.

ON BEHALF OF THE BOARD

“Peter Swistak”

Peter P. Swistak, President/CEO

FOR FURTHER INFORMATION PLEASE CONTACT:

Telephone: 1-604-683-3995

Toll-Free: 1-888-945-4770

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Bougainville Ventures $BOG.ca Provides Corporate Update $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 1:50 PM on Wednesday, April 10th, 2019
  • Announced that further to the letter of intent entered into a funding and profit sharing agreement with Worm Castings Farms Inc.,
  • Continuing to work with Worm Castings regarding its Hemp assets and is close to finalizing the Definitive Agreement with the principals of Worm Castings

VANCOUVER, British Columbia, April 10, 2019 – BOUGAINVILLE VENTURES INC. (CSE: BOG) (8BVFF:Frankfurt Stock Exchange) (the “Company“) would like to announce that further to the letter of intent (“LOI”) entered into a funding and profit sharing agreement with Worm Castings Farms Inc., (“Worm Castings”), announced October 29, 2018, the Company is continuing to work with Worm Castings regarding its Hemp assets and is close to finalizing the Definitive Agreement with the principals of Worm Castings. Worm Castings is the sole owner of an Oregon State Hemp production and processing license, issued by the Oregon State Regulatory approval board. Upon finalization of the transaction Worm Castings will be considering a name change from Worm Castings Farms Inc., to a name that better reflects its Hemp production and CBD processing objectives. In addition,Worm Castings is exploring other Hemp and CBD production and processing related opportunities.

President & CEO, Andy Jagpal Comments:  

“The Farm Bill, which went into effect on January 1, 2019, is a monumental step for the hemp industry, and is a historic event which will create a tremendous amount of opportunities for Hemp farmers, like Worm Castings, whose goal is to produce a Cannabidiol (CBD) product used to treat various ailments and improve wellbeing.“

The Company would also like to announce that, in the name of transparency, until the company is profitable management salaries will be capped at $5,000 per month for each of the two operating directors on an accrued basis. In addition, there is a stock option plan for management and administration which will be 1,950,000 shares with a strike price of 25 cents.

Bougainville’s issued and outstanding share figure on the CSE profile has been updated to 58,625,424 to reflect the changes announced in the news release disseminated April 8, 2019 in which 18,125,000 shares were cancelled. The company has issued 577,883 common shares and 492,883 common share warrants as securities for debt owed to consultants.

About Bougainville Ventures, Inc.  Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost.

For more information please visit: http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-844-734-8420

North Bud Farms Inc. $NBUD.ca – #Cannabis Infused Food Is the Hottest Trend Currently $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 10:16 AM on Wednesday, April 10th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information

NBUD: CSE

—————

Cannabis Infused Food Is the Hottest Trend Currently

  • Three in four cooks stated that CBD- and hashish-infused meals could be a scorching development this year.

By Richard King

The FDA will not approve of this year’s hot meals pattern. The National Restaurant Association and the American Culinary Federation surveyed 650 skilled cooks concerning the original culinary and restaurant ideas for 2019. Three in four cooks stated that CBD- and hashish-infused meals could be a scorching development this year.

 Cooks’ curiosity in hashish and CBD, a non-psychoactive compound discovered within the hashish plant, doesn’t essentially imply that it’s coming to eating places anytime quickly.

Hashish stays unlawful on the general degree, and solely 10 states have legalized it for leisure functions. Some restaurateurs seeking to get in on the pattern with somewhat less scrutiny have turned to personal supper golf equipment that supplies menus with upscale hashish-infused dishes.

That’s true in Canada too; the place edibles received’t are authorized till October regardless of the nation’s 2018 legalization of marijuana.

Chef Travis Petersen travels throughout Canada internet hosting hashish-infused dinners at Airbnb leases. To remain comparatively underneath the radar, he advertises his dinners on social media. A lot of his diners are “canna-curious” and barely nervous about hashish-infused meals, so, for now, he sticks to utilizing odorless, tasteless hashish oil.

Rich shoppers in states like Colorado and Washington — the place the drug is authorized for leisure use – have additionally turned to personal cooks who focus on cannabis-infused meals, in accordance with Donna Hood Crecca, a principal at Technomic.

In the meantime, most CBD merchandise is federally authorized after President Donald Trump signed the farm invoice again in December. Nonetheless, the Food and Drug Administration prohibits including CBD to meals and drinks as a result of it’s an energetic ingredient in an FDA-authorized drug. The regulator has set its first public hearing on legalizing CBD in food and drinks for May 31.

That hasn’t stopped some eating places from promoting CBD-infused merchandise to reply to client demand. CBD, brief for cannabidiol, is pitched as serving to the physique loosen up without altering the thoughts like THC.

Source: https://foodindustryupdates.com/2019/04/08/271/cannabis-infused-food-is-the-hottest-trend-currently/

Bougainville Ventures $BOG.ca Cancels Deal with Gene Bank Research Inc. $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 1:20 PM on Monday, April 8th, 2019
  • Terminated the previously announced November 13, 2018, transaction and underlying agreement with Gene Bank Research Inc.

VANCOUVER, British Columbia, April 08, 2019 – BOUGAINVILLE VENTURES INC. (CSE: BOG) (8BVFF:Frankfurt Stock Exchange) (the “Company“) has terminated the previously announced November 13, 2018, transaction and underlying agreement with Gene Bank Research Inc.

With respect to its transaction (“Transaction”) involving Gene Bank Research Inc., the company worked with its legal counsel to determine that Gene Bank defaulted on representations it entered into in the Share Exchange Agreement. Subject to Section 7.1(c) of the Share Exchange Agreement the Company has to terminate the contract.

Of the 25,000,000 shares initially issued 18,125,000 shares of Bougainville stock will be cancelled and returned to the company treasury. The remaining 6,875,000 share of Bougainville stock were already deposited into CDS and were unable to be cancelled, but the Company is still actively trying to cancel the remaining stock. As part of the termination of the agreement the Company will be returning any and all intellectual property, genetic material belonging to Gene Bank Research Inc.

About Bougainville Ventures, Inc.  Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost.

For more information please visit: http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-888-395-6399

Applied Biosciences $APPB Retains the Emmes Group to Partner on Therapeutic Development Initiatives $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM at 10:38 AM on Monday, April 8th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • Retained the Emmes Group to assist with the development and execution of the Company’s partnership and technology licensing initiatives and strategies.
  • The Company believes that by assembling a well-versed and well-seasoned group of individuals involved in different facets of the medical and scientific business model, the Company will be able to successfully execute and achieve its corporate and therapeutic development goals.

LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and pet health industries, announced that is has retained the Emmes Group to assist with the development and execution of the Company’s partnership and technology licensing initiatives and strategies.

Through this new partnership, Emmes and the Company will work together to formulate a line of medical and scientific focused cannabidiol (“CBD”) based products to target the endocannabinoid system under the “Applied BioPharma” brand.

Applied BioSciences has retained several industry leading individuals as scientific advisory board members and in corporate management consultative capacities. The Company believes that by assembling a well-versed and well-seasoned group of individuals involved in different facets of the medical and scientific business model, the Company will be able to successfully execute and achieve its corporate and therapeutic development goals.

“I am pleased to have the opportunity to work with the Emmes Group, and Martin Schroeder, EVP & Managing Director,” said Chris Bridges, President. “Mr. Schroeder and his colleagues at the Emmes Group have been responsible for helping to build cell therapy assets and developing and executing the business initiatives and licensing strategies for many biotech and pharmaceutical initiatives.” Mr. Bridges further stated.

About Applied BioSciences Corp.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to multiple International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and pet industries.

About Trace Analytics Inc.

Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology. The focus of the team is to ensure compliance with public safety standards andend user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com.

About Emmes Group

The Emmes Group is a strategy consulting and market research organization supporting firms engaged in the technology and healthcare industries. Our partners have over 50 years of combined experience. We work in partnership with our clients to increase profits and build lasting economic value. Our expertise spans a number of key areas, including: Strategy Consulting, Partnerships, Mergers & Acquisitions, Strategic Marketing, Market Research & Modeling, Business Development, Technology Licensing, Corporate Financing and, Venture Capital Due Diligence. http://www.emmesgroup.com.

Contact

Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:

www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:

Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

CLIENT FEATURE: NORTHBUD $NBUD.ca Signs $20 MILLION Binding LOI For Acquisition of Multi-State Licensed Operator Eureka Vapor $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:26 PM on Thursday, April 4th, 2019

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    as shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products

NORTHBUD Signs Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.

Bougainville Ventures $BOG.ca Begins Site Preparation in Washington State, Oroville Campus $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 4:29 PM on Monday, April 1st, 2019
  • Announced that its first 10,000 square foot cultivation facility in Oroville, WA will be occupied by a Tier-3, I-502 tenant starting June 01, 2019.
  • Tenant is currently in the process of obtaining occupancy approval from the Washington State Liquor and Cannabis Board to begin planting the Tenant’s crop for the season.
  • In addition to the 10,000 sq. ft. space, Tenant is planning to plant a 20,000 sq. ft. out-door crop. The Tenant is licensed to build out up to 30,000 square feet on the existing property in Oroville, WA.

VANCOUVER, British Columbia, April 01, 2019 – BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE: BOG), providing cannabis infrastructure and seed-to-sale services to I-502 tenant-growers, is pleased to announce that its first 10,000 square foot cultivation facility in Oroville, WA will be occupied by a Tier-3, I-502 tenant (the “Tenant”) starting June 01, 2019. The Tenant is currently in the process of obtaining occupancy approval from the Washington State Liquor and Cannabis Board (WSLCB) to begin planting the Tenant’s crop for the season. In addition to the 10,000 sq. ft. space the Tenant is planning to plant a 20,000 sq. ft. out-door crop. The Tenant is licensed to build out up to 30,000 square feet on the existing property in Oroville, WA.

CEO, Andy Jagpal Comments: 
“We are excited to see our first Tier-3, I-502 tenant move forward towards a successful growing season. This first planting season signals a new phase for Bougainville concept of providing fully built out turnkey facilities to cannabis growers and processors.These facilities remove financial barriers for cannabis cultivators as traditional funding can be limited. In addition, steps are being taken to get a second tenant up and running for the 2019 growing season. We are moving towards our goal of revenue generating self-sufficiency.”

About the Washington I-502 Marijuana Market 
In November 2012, the Washington State Liquor Control Board (WSLCB) passed Initiative 502 (I-502) pursuant to a vote by the people of the State of Washington. I-502 authorized the WSLCB to regulate and tax recreational marijuana products for persons over twenty-one years of age and thereby created a new industry for growing, processing and selling of Washington State-regulated recreational marijuana products. A recent WSLCB commissioned report by the Rand organization suggests that there are currently up to 650,000 recreational marijuana users in Washington State, worth approximately $1.25 – $1.5 billion USD in annual sales. 

About Bougainville Ventures, Inc. 
Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost. Bougainville has 10,000 sq.ft., in near production in Oroville, WA, sufficient land for two more pods of the same size.

For more information please visit: http://bougainvilleinc.com/ 

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC. 
_____________________
Andy Jagpal, CEO and Director 

For further information, please contact the IR department at [email protected] or by phone at 1-877-517-7816.

Marijuana Company of America $MCOA Provides Update on Processing of Hemp from Oregon Joint Venture $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 9:17 AM on Monday, April 1st, 2019
  • Announced that they are currently in negotiations with several cannabinoid extraction companies in Oregon, regarding the acquisition of the joint venture’s hemp biomass produced at the Scio farm from the 2018 harvest.
  • The team at the Scio farm has prepared processing samples ranging in size from 100 lbs to 2,000 lbs. for the extraction companies

Escondido, California–(April 1, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, and its Joint Venture partner Global Hemp Group (CSE: GHG) (OTC: GBHPF) (FSE: GHG) (together with the Company, the “Partners“) are pleased to announce that they are currently in negotiations with several cannabinoid extraction companies in Oregon, USA, regarding the acquisition of the joint venture’s hemp biomass produced at the Scio farm from the 2018 harvest. The team at the Scio farm has prepared processing samples ranging in size from 100 lbs to 2,000 lbs. for the extraction companies. The biomass is being processed into CBD crude oil with the option to refine it further into isolate, or full spectrum oil, in order to increase its value on the market. Results from the current extraction test batches are expected to be received by mid-April and will serve as a basis for the final terms of the sale of the biomass by the Partners.

Cloning Update

The cloning process is well underway at the Scio farm. For this year’s cultivation, four different strains have been chosen from the latest high CBD industrial hemp varieties, which are being used as a base for the in-house propagation program. The goal of the program is to produce approximately 50,000 clones to populate the lower 35 acres of the Scio farm for the 2019 season, and reduce and/or eliminate the need for the acquisition of any additional seeds or clones from outside sources. The program started with 400 high quality plants. Through a regimen of proper nutrients and a controlled environment, these “mother” plants will grow into very large bushes, which will be used to derive a sufficient number of clones, ensuring that the target number of plants required for this year’s cultivation is reached. Once removed from the mother plants, the clones will then be placed in a propagation greenhouse to root. Once rooted and well established, the clones will then be ready to be planted in the fields, which is expected to begin this year in late May or early June.

Expansion in 2019

The Company continues to evaluate a number of opportunities to expand the scope of its project in Oregon. As previously announced, a number of local farmers are interested in working with the joint venture partners to grow hemp in 2019. The Oregon Department of Agriculture expects hemp cultivation in Oregon to grow from 11,514 acres in 2018 to more than 25,000 in this current year. In order for new hemp farmers to be successful, they will need to rely on experienced hemp farming teams like our Scio farm team. This will create potential opportunity to joint venture with the local farming community.

Micropropagation (Tissue Culture)

The Company has begun preliminary exploration to expand its business into micropropagation of hemp plants. By focusing on culturing the tissue from feminized “mother” hemp plants that are proven to produce high CBD levels, the Company believes it can more efficiently provide plants with higher-yielding and more profitable CBD content. Micropropagation techniques rely on uniform tissue sampling from high yielding CBD feminized hemp plants, that is more effective than developing plants from the more traditional methods of germination from seed or cloning from other plants.

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

About Global Hemp Group Inc.

Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FSE: GHG), is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in New Brunswick and Oregon. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Marijuana Company of America $MCOA Enters Strategic Partnership with Massroots to Promote the hempSMART CBD Product Line $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca $MSRT

Posted by AGORACOM-JC at 8:12 AM on Tuesday, March 26th, 2019
  • Announced that the Company’s wholly owned subsidiary hempSMART™ has entered into a strategic marketing agreement with MassRoots, Inc. (OTCQB: MSRT) to promote its hemp CBD formulated product line.
  • Under the terms of the agreement, MassRoots agreed to participate as an associate in the Company’s associate marketing platform, to help promote and sell hempSMART™ products on www.massroots.com, as well as MassRoots’ app and other social media outlets.

Escondido, California–(March 26, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary hempSMART™ has entered into a strategic marketing agreement with MassRoots, Inc. (OTCQB: MSRT) to promote its hemp CBD formulated product line.

Under the terms of the agreement, MassRoots agreed to participate as an associate in the Company’s associate marketing platform, to help promote and sell hempSMART™ products on www.massroots.com, as well as MassRoots’ app and other social media outlets.

“We’re excited to begin educating MassRoots’ community of over a million cannabis consumers about hempSMART’s™ innovative line of CBD products,” stated MassRoots’ Chief Executive Officer Isaac Dietrich. “We look forward to driving our audience to a company that focuses on providing consumers with the highest-quality of ingredients and products, which is ultimately why we’re partnering with MCOA.”

CEO of MCOA, Donald Steinberg, stated, “We are very proud to have the hempSMART™ CBD product line accepted by MassRoots as part of their marketing campaign. We are anticipating increased visibility for our product line by utilizing such a widely recognized media platform involved in the cannabis industry.”

About MassRoots

MassRoots, Inc. is a leading technology platform for the regulated cannabis industry. Powered by more than one million registered users, the Company’s mobile apps empower consumers to make educated cannabis purchasing decisions through community-driven reviews. Its rewards program, WeedPassTM, enables consumers to earn tickets to movies, sporting events, and festivals by shopping at participating dispensaries. MassRoots has been covered by CNN, CNBC, Fox Business, Fortune, Forbes, and Reuters. For more information, please visit www.MassRoots.com/Investors and review MassRoots’ filings with the U.S. Securities and Exchange Commission.

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]